BioVex ^Companies

BioVex is a biotechnology company that specializes in developing and commercializing biological treatments for cancer and infectious diseases. Their main focus is on their cancer program, OncoVEXGM-CSF, which is an oncolytic vaccine that targets and destroys cancer cells while leaving healthy cells unharmed. This vaccine has been tested in over 110 patients with various types of solid tumors, including melanoma, head and neck cancer, breast cancer, and pancreatic cancer. The results have shown that OncoVEXGM-CSF not only kills tumors directly but also stimulates a powerful immune response against the cancer cells. This treatment has led to overall disease responses in multiple patients and has shown no recurrence of tumors.